Oruka Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Oruka Therapeutics, Inc. (ORKA) had Operating Lease, Weighted Average Discount Rate, Percent of 13.07% as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-03-12
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 13.07%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 17.95%.
- 2024-06-30: Operating Lease, Weighted Average Discount Rate, Percent 7.00%.
- 2024-03-31: Operating Lease, Weighted Average Discount Rate, Percent 7.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 13.07% 10-K · filed 2026-03-12 |
| 2024-12-31 | 17.95% 10-K · filed 2026-03-12 |
| 2024-06-30 | 7.00% 10-Q · filed 2024-08-01 |
| 2024-03-31 | 7.00% 10-Q · filed 2024-04-25 |
| 2023-12-31 | 7.00% 10-K · filed 2024-02-01 |
| 2023-09-30 | 7.00% 10-Q · filed 2023-10-18 |
| 2023-06-30 | 7.00% 10-Q · filed 2023-07-21 |
| 2023-03-31 | 7.00% 10-Q · filed 2023-04-24 |
| 2022-12-31 | 7.00% 10-K · filed 2023-02-24 |
| 2022-09-30 | 7.00% 10-Q · filed 2022-10-28 |
| 2022-06-30 | 7.00% 10-Q · filed 2022-08-02 |
| 2022-03-31 | 7.00% 10-Q · filed 2022-05-02 |
| 2021-12-31 | 7.00% 10-K · filed 2022-03-14 |
| 2021-09-30 | 7.00% 10-Q · filed 2021-11-02 |
| 2021-06-30 | 7.00% 10-Q · filed 2021-08-04 |
| 2021-03-31 | 7.00% 10-Q · filed 2021-05-11 |
| 2020-12-31 | 7.00% 10-K · filed 2021-03-18 |
| 2020-08-29 | 7.00% 10-Q · filed 2022-10-28 |
| 2020-06-30 | 7.50% 10-Q · filed 2020-08-05 |
| 2020-03-31 | 7.50% 10-Q · filed 2020-05-06 |
| 2019-12-31 | 7.50% 10-K · filed 2020-02-18 |
| 2019-09-30 | 7.50% 10-Q · filed 2019-11-06 |
| 2019-06-30 | 7.50% 10-Q · filed 2019-08-01 |
| 2019-03-31 | 7.50% 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |